Journal
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
Volume 52, Issue 14, Pages 3985-3988Publisher
WILEY-V C H VERLAG GMBH
DOI: 10.1002/anie.201208556
Keywords
cystic fibrosis; DNA nanoparticles; gene therapy; mucus-penetrating particles; nanotechnology
Categories
Funding
- National Heart, Lung, and Blood Institute [P01L51811, F32L103137]
- National Institute of Biomedical Imaging and Bioengineering [R01EB003558]